A discussion on the widespread shortage of popular generic medications in the US and its impact on patients across different areas of healthcare.
Bloomberg’s Ike Swetlitz and Riley Griffin join this episode to discuss what’s driving the shortage of generic drugs in the US, including amoxicillin, and what can be done to restore supplies.